Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 21, 2024
Preclinical studies of gene replacement therapy for CDKL5 deficiency disorder
Gregory Voronin, Jana Narasimhan, Jamila Gittens, et al.
Scientific Reports
|
January 23, 2021
The combination of the tubulin binding small molecule PTC596 and proteasome inhibitors suppresses the growth of myeloma cells
Yurie Nagai, Naoya Mimura, Ola Rizq, et al.
Cancer Research Communications
|
March 28, 2024
Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
Giorgia Maroni, Indira Krishnan, Roberta Alfieri, et al.
Biorxiv : the Preprint Server for Biology
|
August 15, 2020
The DHODH Inhibitor PTC299 Arrests SARS-CoV-2 Replication and Suppresses Induction of Inflammatory Cytokines
Jeremy Luban, Rachel Sattler, Elke Mühlberger, et al.
Journal of Medicinal Chemistry
|
November 26, 2013
Structure-activity relationship (SAR) optimization of 6-(indol-2-yl)pyridine-3-sulfonamides: identification of potent, selective, and orally bioavailable small molecules targeting hepatitis C (HCV) NS4B
Nanjing Zhang, Xiaoyan Zhang, Jin Zhu, et al.
Virus Research
|
November 29, 2020
The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines
Jeremy Luban, Rachel A Sattler, Elke Mühlberger, et al.
Journal of Medicinal Chemistry
|
June 15, 2016
Specific Correction of Alternative Survival Motor Neuron 2 Splicing by Small Molecules: Discovery of a Potential Novel Medicine To Treat Spinal Muscular Atrophy
Hasane Ratni, Gary M Karp, Marla Weetall, et al.
Nature Communications
|
December 16, 2021
Small molecule splicing modifiers with systemic HTT-lowering activity
Anuradha Bhattacharyya, Christopher R Trotta, Jana Narasimhan, et al.
Science Translational Medicine
|
January 28, 2021
Impaired prenatal motor axon development necessitates early therapeutic intervention in severe SMA
Lingling Kong, David O Valdivia, Christian M Simon, et al.
Journal of Medicinal Chemistry
|
July 26, 2018
Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 ( SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA)
Hasane Ratni, Martin Ebeling, John Baird, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 21, 2024
Preclinical studies of gene replacement therapy for CDKL5 deficiency disorder
Gregory Voronin, Jana Narasimhan, Jamila Gittens, et al.
Scientific Reports
|
January 23, 2021
The combination of the tubulin binding small molecule PTC596 and proteasome inhibitors suppresses the growth of myeloma cells
Yurie Nagai, Naoya Mimura, Ola Rizq, et al.
Cancer Research Communications
|
March 28, 2024
Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
Giorgia Maroni, Indira Krishnan, Roberta Alfieri, et al.
Biorxiv : the Preprint Server for Biology
|
August 15, 2020
The DHODH Inhibitor PTC299 Arrests SARS-CoV-2 Replication and Suppresses Induction of Inflammatory Cytokines
Jeremy Luban, Rachel Sattler, Elke Mühlberger, et al.
Journal of Medicinal Chemistry
|
November 26, 2013
Structure-activity relationship (SAR) optimization of 6-(indol-2-yl)pyridine-3-sulfonamides: identification of potent, selective, and orally bioavailable small molecules targeting hepatitis C (HCV) NS4B
Nanjing Zhang, Xiaoyan Zhang, Jin Zhu, et al.
Virus Research
|
November 29, 2020
The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines
Jeremy Luban, Rachel A Sattler, Elke Mühlberger, et al.
Journal of Medicinal Chemistry
|
June 15, 2016
Specific Correction of Alternative Survival Motor Neuron 2 Splicing by Small Molecules: Discovery of a Potential Novel Medicine To Treat Spinal Muscular Atrophy
Hasane Ratni, Gary M Karp, Marla Weetall, et al.
Nature Communications
|
December 16, 2021
Small molecule splicing modifiers with systemic HTT-lowering activity
Anuradha Bhattacharyya, Christopher R Trotta, Jana Narasimhan, et al.
Science Translational Medicine
|
January 28, 2021
Impaired prenatal motor axon development necessitates early therapeutic intervention in severe SMA
Lingling Kong, David O Valdivia, Christian M Simon, et al.
Journal of Medicinal Chemistry
|
July 26, 2018
Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 ( SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA)
Hasane Ratni, Martin Ebeling, John Baird, et al.
Page
of 7